STAT August 6, 2024
Life science venture capital firms are pacing for another record-low year of fundraising, potentially hindering the amount of money that startups can draw from over the next several years.
In the first half of the year, the industry’s VC firms have raised just 15 pools of capital from wealthy individuals, sovereign wealth funds, pension funds, or university endowments. That’s down from 53 funds last year and 85 funds in 2022, according to data from Pitchbook.
Many...
Today's Sponsors
Today's Sponsor